99% Savings - Buy Just @1 Rs X
Methastar 0.125 mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Post Delivery Bleeding.
The optimal dosage of Methastar 0.125 mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Methastar 0.125 mg Tablet include Headache, Abdominal Pain, Hypertension. While these are the most often observed Methastar 0.125 mg Tablet side effects, there are can be others also. These have been listed below. These side effects of Methastar 0.125 mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Methastar 0.125 mg Tablet is Unknown for pregnant women and Unknown for women who are breastfeeding. Warnings related to Methastar 0.125 mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Methastar 0.125 mg Tablet is contraindicated in people with pre-existing medical conditions like High Blood Pressure as it can result in adverse effects. The section on Methastar 0.125 mg Tablet contraindications lists all such conditions.
Besides this, Methastar 0.125 mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Methastar 0.125 mg Tablet is considered safe while driving, and is addictive.
Methastar 0.125 mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Methastar 0.125 mg Tablet safe for pregnant women?
It is not known what effect Methastar will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Methastar 0.125 mg Tablet safe during breastfeeding?
No research work has been carried out till date on effect of Methastar on breastfeeding women. So it is not known whether taking Methastar will cause side effects or not.
What is the effect of Methastar 0.125 mg Tablet on the Kidneys?
Methastar has very mild side effects on the kidneys.
What is the effect of Methastar 0.125 mg Tablet on the Liver?
Methastar may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Methastar 0.125 mg Tablet on the Heart?
Methastar can cause side effects that could harm the heart. So medical advice before taking it is necessary.
If you are suffering from any of the following diseases, you should not take Methastar 0.125 mg Tablet unless your doctor advises you to do so -
Is this Methastar 0.125 mg Tablet habit forming or addictive?
Methastar 0.125 mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Methastar 0.125 mg Tablet as it does not make you drowsy.
Is it safe?
Methastar 0.125 mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Methastar 0.125 mg Tablet is not used to treat mental disorders.
Interaction between Food and Methastar 0.125 mg Tablet
Due to a lack of research, nothing can be said about the consequences of taking Methastar 0.125 mg Tablet together with food.
Interaction between Alcohol and Methastar 0.125 mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Methastar 0.125 mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839